Mirador Therapeutics, Inc.

New Filing
CIK: 0002017193·Other Health Care·DELAWARE·Filed: Apr 3, 2024
Total Offering

$80,000,000

Amount Sold

$80,000,000

Investors

3

First Sale

Dec 14, 2023

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Mark C. McKenna
Related Person
Timothy K. Andrews
Related Person
Vika Brough
Related Person
Paul Berns
Related Person
David Bonita, M.D.
Related Person
Kristina Burow
Related Person
Scott Glenn
Related Person
Joseph Papa
Related Person

Company

Mirador Therapeutics, Inc.

3115 Merryfield Row, Suite 210

San Diego, CA, 92121

(858) 523-5400

SEC Filing

0002017193-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free